{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T21:58:37Z","timestamp":1764194317046,"version":"3.37.3"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,14]],"date-time":"2018-11-14T00:00:00Z","timestamp":1542153600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010663","name":"H2020 European Research Council","doi-asserted-by":"publisher","award":["6710055"],"award-info":[{"award-number":["6710055"]}],"id":[{"id":"10.13039\/100010663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Dis Poverty"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s40249-018-0496-2","type":"journal-article","created":{"date-parts":[[2018,10,29]],"date-time":"2018-10-29T11:27:32Z","timestamp":1540812452000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["The effect of bi-annual community-directed treatment with ivermectin on the incidence of epilepsy in onchocerciasis endemic villages in South Sudan: a study protocol"],"prefix":"10.1186","volume":"7","author":[{"given":"Gasim","family":"Abd-Elfarag","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoy Yibi","family":"Logora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane Y.","family":"Carter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morrish","family":"Ojok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jackson","family":"Songok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia","family":"Menon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ferdinand","family":"Wit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Lako","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1919-1340","authenticated-orcid":false,"given":"Robert","family":"Colebunders","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,11,14]]},"reference":[{"key":"496_CR1","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.3201\/eid1909.130401","volume":"19","author":"SF Dowell","year":"2013","unstructured":"Dowell SF, Sejvar JJ, Riek L, Vandemaele KAH, Lamunu M, Kuesel AC, et al. Nodding syndrome. Emerg Infect Dis. 2013;19:1374\u201384.","journal-title":"Emerg Infect Dis"},{"key":"496_CR2","doi-asserted-by":"publisher","first-page":"e002540","DOI":"10.1136\/bmjopen-2012-002540","volume":"3","author":"R Idro","year":"2013","unstructured":"Idro R, Opoka RO, Aanyu HT, Kakooza-Mwesige A, Piloya-Were T, Namusoke H, et al. Nodding syndrome in Ugandan children-clinical features, brain imaging and complications: a case series. BMJ Open. 2013;3:e002540.","journal-title":"BMJ Open"},{"key":"496_CR3","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/S1474-4422(12)70321-6","volume":"12","author":"JJ Sejvar","year":"2013","unstructured":"Sejvar JJ, Kakooza AM, Foltz JL, Makumbi I, Atai-Omoruto AD, Malimbo M, et al. Clinical, neurological, and electrophysiological features of nodding syndrome in Kitgum, Uganda: an observational case series. Lancet Neurol. 2013;12:166\u201374.","journal-title":"Lancet Neurol"},{"key":"496_CR4","volume-title":"Nodding syndrome (NS)","author":"World Health Organisation","year":"2017","unstructured":"World Health Organisation: Nodding syndrome (NS). 2017. \n                    http:\/\/www.who.int\/onchocerciasis\/symptoms\/nodding_syndrome\/en\/\n                    \n                  . Accessed 27 Sept 2018."},{"key":"496_CR5","first-page":"305","volume":"1","author":"WG Jilek","year":"1970","unstructured":"Jilek WG, Jilek-Aall LM. The problem of epilepsy in a rural Tanzanian tribe. Afr J Med Sci. 1970;1:305\u20137.","journal-title":"Afr J Med Sci"},{"key":"496_CR6","first-page":"242","volume":"12","author":"JK Tumwine","year":"2012","unstructured":"Tumwine JK, Vandemaele K, Chungong S, Richer M, Anker M, Ayana Y, et al. Clinical and epidemiologic characteristics of nodding syndrome in Mundri County, southern Sudan. Afr Health Sci. 2012;12:242\u20138.","journal-title":"Afr Health Sci"},{"key":"496_CR7","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/S1474-4422(03)00599-4","volume":"2","author":"M Lacey","year":"2003","unstructured":"Lacey M. Nodding disease: mystery of southern Sudan. Lancet Neurol. 2003;2:714 M. L. Nodding disease: mystery of southern Sudan. Lancet Neurol. 2003;2:714.","journal-title":"Lancet Neurol"},{"key":"496_CR8","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1111\/j.1528-1167.2009.02280.x","volume":"50","author":"C Kaiser","year":"2009","unstructured":"Kaiser C, Sb P, Boussinesq M. Head nodding syndrome and river blindness: a parasitologic perspective. Epilepsia. 2009;50:2325\u201330.","journal-title":"Epilepsia"},{"key":"496_CR9","doi-asserted-by":"publisher","first-page":"e461","DOI":"10.1371\/journal.pntd.0000461","volume":"3","author":"SD Pion","year":"2009","unstructured":"Pion SD, Kaiser C, Boutros-Toni F, Cournil A, Taylor MM, Meredith SE, et al. Epilepsy in onchocerciasis endemic areas: systematic review and meta-analysis of population-based surveys. PLoS Negl Trop Dis. 2009;3:e461.","journal-title":"PLoS Negl Trop Dis"},{"key":"496_CR10","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.pt.2017.11.009","volume":"34","author":"R Colebunders","year":"2018","unstructured":"Colebunders R, Nelson Siewe FJ, Hotterbeekx A. Onchocerciasis-associated epilepsy, an additional reason for strengthening onchocerciasis elimination programs. Trends Parasitol. 2018;34:208\u201316.","journal-title":"Trends Parasitol"},{"issue":"377","key":"496_CR11","doi-asserted-by":"publisher","first-page":"eaaf6953","DOI":"10.1126\/scitranslmed.aaf6953","volume":"9","author":"Tory P. Johnson","year":"2017","unstructured":"Johnson TP, Tyagi R, Lee PR, Lee MH, Johnson KR, Kowalak J, et al. Nodding syndrome may be an autoimmune reaction to the parasitic worm Onchocerca volvulus. Sci Transl Med. 2017;9(377). \n                    https:\/\/doi.org\/10.1126\/scitranslmed.aaf6953\n                    \n                  .","journal-title":"Science Translational Medicine"},{"key":"496_CR12","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1186\/s13104-016-1993-7","volume":"9","author":"R Colebunders","year":"2016","unstructured":"Colebunders R, Hendy A, Mokili JL, Wamala JF, Kaducu J, Kur L, et al. Nodding syndrome and epilepsy in onchocerciasis endemic regions: comparing preliminary observations from South Sudan and the Democratic Republic of the Congo with data from Uganda. BMC Res Notes. 2016;9:182.","journal-title":"BMC Res Notes"},{"key":"496_CR13","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.ijid.2014.08.001","volume":"27","author":"R Colebunders","year":"2014","unstructured":"Colebunders R, Hendy A, Nanyunja M, Wamala JF, van Oijen M. Nodding syndrome-a new hypothesis and new direction for research. Int J Infect Dis. 2014;27:74\u20137.","journal-title":"Int J Infect Dis"},{"key":"496_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1756-3305-7-325","volume":"7","author":"M Noma","year":"2014","unstructured":"Noma M, Zour\u00e9 HG, Tekle AH, Enyong PA, Nwoke BE, Remme JH. The geographic distribution of onchocerciasis in the 20 participating countries of the African Programme for onchocerciasis control: (1) priority areas for ivermectin treatment. Parasite Vector. 2014;7:1\u201315.","journal-title":"Parasite Vector"},{"key":"496_CR15","volume-title":"Neglected tropical diseaeses and their control in South Sudan. Situation analysis, intervention options, appraisal and gap analysis","author":"Ministry of Health South Sudan","year":"2008","unstructured":"Ministry of Health South Sudan: Neglected tropical diseaeses and their control in South Sudan. Situation analysis, intervention options, appraisal and gap analysis. 2008. \n                    https:\/\/www.malariaconsortium.org\/userfiles\/file\/NTD%20Resources\/ntds_southern_sudan%5B1%5D.pdf\n                    \n                  . Acessed 27 Sept 2018."},{"key":"496_CR16","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1017\/S0007485300026705","volume":"43","author":"DJ Lewis","year":"1953","unstructured":"Lewis DJ. Simulium damnosum and its relation to onchocerciasis in the Anglo-Egyptian Sudan. Bull Entomol Res. 1953;43:597\u201364.","journal-title":"Bull Entomol Res"},{"key":"496_CR17","doi-asserted-by":"publisher","first-page":"e1210","DOI":"10.1371\/journal.pntd.0001210","volume":"5","author":"HGM Zoure\u2019","year":"2011","unstructured":"Zoure\u2019 HGM, Wanji S, Ml N, Amazigo UV, Diggle PJ, Tekle AH, et al. The geographic distribution of Loa loa in Africa: results of large-scale implementation of the rapid assessment procedure for Loiasis (RAPLOA). PLoS Negl Trop Dis. 2011;5:e1210.","journal-title":"PLoS Negl Trop Dis"},{"key":"496_CR18","doi-asserted-by":"publisher","first-page":"e0003880","DOI":"10.1371\/journal.pntd.0003880","volume":"9","author":"JF Wamala","year":"2015","unstructured":"Wamala JF, Malimbo M, Tepage F, Lukwago L, Okot CL, Cannon RO, et al. Nodding syndrome may be only the ears of the hippo. PLoS Negl Trop Dis. 2015;9:e0003880.","journal-title":"PLoS Negl Trop Dis"},{"key":"496_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijid.2016.05.018","volume":"49","author":"R Colebunders","year":"2016","unstructured":"Colebunders R, Mandro M, Mokili JL, Mucinya G, Mambandu G, Pfarr K, et al. Risk factors for epilepsy in bas-Uele Province, Democratic Republic of the Congo: a case-control study. Int J Infect Dis. 2016;49:1\u20138.","journal-title":"Int J Infect Dis"},{"key":"496_CR20","doi-asserted-by":"publisher","first-page":"e0005732","DOI":"10.1371\/journal.pntd.0005732","volume":"11","author":"B Levick","year":"2017","unstructured":"Levick B, Laudisoit A, Tepage F, Ensoy-Musoro C, Mandro M, Bonareri Osoro C, et al. High prevalence of epilepsy in onchocerciasis endemic regions in the Democratic Republic of the Congo. PLoS Negl Trop Dis. 2017;11:e0005732.","journal-title":"PLoS Negl Trop Dis"},{"key":"496_CR21","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.ijid.2016.01.016","volume":"44","author":"R Colebunders","year":"2016","unstructured":"Colebunders R, Irani J, Post R. Nodding syndrome-we can now prevent it. Int J Infect Dis. 2016;44:61\u20133.","journal-title":"Int J Infect Dis"},{"key":"496_CR22","first-page":"12","volume-title":"1st international workshop on onchocerciasis associated epilepsy","author":"AK Njamnshi","year":"2017","unstructured":"Njamnshi AK, Zoung-Kanyi Bissek AC, Tabah EN, et al. Age shift of persons with epilepsy in Bilomo, Cameroon, following ivermectin mass drug administration for onchocerciasis. In: 1st international workshop on onchocerciasis associated epilepsy; 2017. p. 12\u20134. Antwerp, Belgium. \n                    https:\/\/www.uantwerpen.be\/images\/uantwerpen\/container42952\/files\/20171023%20Programma%20boekje%20FINAL.pdf\n                    \n                  . Accessed 27 Sept 2018."},{"key":"496_CR23","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/0140-6736(92)92329-E","volume":"340","author":"W Kipp","year":"1992","unstructured":"Kipp W, Burnham G, Kamugisha J. Improvement in seizures after ivermectin. Lancet. 1992;340:789\u201390.","journal-title":"Lancet"},{"key":"496_CR24","volume-title":"Population distribution by age group by sex by payam. Edited by release M, vol. 2: National Bureau of Statistics","author":"National Bureau of Statistics","year":"2013","unstructured":"National Bureau of Statistics. Population dustribution by age group by sex by payam. In: Population distribution by age group by sex by payam. Edited by release M, vol. 2: National Bureau of Statistics; 2013. \n                    http:\/\/www.ssnbss.org\/home\/document\/census\/population-distribution-by-age-group-sex-and-payam-greater-bahr-el-ghazal\n                    \n                  . Accessed 27 Sept 2018."},{"key":"496_CR25","volume-title":"Situation Overview: Displacement and Intentions in Greater Equatoria","author":"REACH initiative","year":"2016","unstructured":"REACH initiative: Situation Overview: Displacement and Intentions in Greater Equatoria. 2016. \n                    https:\/\/reliefweb.int\/report\/south-sudan\/south-sudan-situation-overview-displacement-and-intentions-greater-equatoria-2\n                    \n                  . Accessed 27 Sept 2018."},{"key":"496_CR26","first-page":"103","volume":"99","author":"M Diagana","year":"2006","unstructured":"Diagana M, Preux PM, Tuillas M, Ould Hamady A, Druet-Cabanac M. Depistage de l\u2019epilepsie en zones tropicales: validation d'un questionnaire en Mauritanie. Bull Soc Pathol Exot. 2006;99:103\u20137 Depistage de l'epilepsie en zones tropicales: validation d'un questionnaire en Mauritanie.","journal-title":"Bull Soc Pathol Exot"},{"key":"496_CR27","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1111\/epi.12550","volume":"55","author":"RS Fisher","year":"2014","unstructured":"Fisher RS, Acevedo C, Arzimanoglou A, Bogacz A, Helen Cross J, Elger CE, et al. A practical clinical definition of epilepsy. Epilepsia. 2014;55:475\u201382.","journal-title":"Epilepsia"},{"key":"496_CR28","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1016\/S1474-4422(14)70114-0","volume":"13","author":"A Ba-Diop","year":"2014","unstructured":"Ba-Diop A, Marin B, Druet-Cabanac M, Ngoungou EB, Newton CR, Preux PM. Epidemiology, causes, and treatment of epilepsy in sub-Saharan Africa. Lancet Neurol. 2014;13:1029\u201344.","journal-title":"Lancet Neurol"},{"key":"496_CR29","first-page":"219","volume":"13","author":"R Idro","year":"2013","unstructured":"Idro R, Musubire KA, Byamah Mutamba B, Namusoke H, Muron J, Abbo C, et al. Proposed guidelines for the management of nodding syndrome. Afr Health Sci. 2013;13:219\u201332.","journal-title":"Afr Health Sci"},{"key":"496_CR30","doi-asserted-by":"publisher","first-page":"a45","DOI":"10.1111\/j.1365-3156.2004.01213.x","volume":"9","author":"JM Tielsch","year":"2004","unstructured":"Tielsch JM, Beeche A. Impact of ivermectin on illness and disability associated with onchocerciasis. Tropical Med Int Health. 2004;9:a45\u201356.","journal-title":"Tropical Med Int Health"},{"key":"496_CR31","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/S0920-1211(98)00007-2","volume":"30","author":"C Kaiser","year":"1998","unstructured":"Kaiser C, Asaba G, Leichsenring M, Kabagambe G. High incidence of epilepsy related to onchocerciasis in West Uganda. Epilepsy Res. 1998;30:247\u201351.","journal-title":"Epilepsy Res"},{"issue":"2015","key":"496_CR32","first-page":"661","volume":"49","author":"WHO","year":"2015","unstructured":"WHO. African Programme for onchocerciasis control: progress report, 2014\u20132015. Wkly Epidemiol Rec. 2015;49(2015):661\u201380.","journal-title":"Wkly Epidemiol Rec"},{"key":"496_CR33","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1093\/cid\/ciu467","volume":"2014","author":"HC Turner","year":"2014","unstructured":"Turner HC, Walker M, Churcher TS, Osei-Atweneboana MY, Biritwum N-K, Hopkins A, et al. Reaching the London declaration on neglected tropical diseases goals for onchocerciasis: an economic evaluation of increasing the frequency of Ivermectin treatment in Africa. Clin Infect Dis. 2014;2014:923\u201332.","journal-title":"Clin Infect Dis"},{"key":"496_CR34","volume-title":"Department of control of neglected tropical diseases: Guidelines for stopping mass drug administration and verifying elimination of human onchocerciasis: criteria and procedures","author":"World Health Organisation","year":"2016","unstructured":"World Health Organisation. Department of control of neglected tropical diseases: Guidelines for stopping mass drug administration and verifying elimination of human onchocerciasis: criteria and procedures. Geneva: Who\/HTM\/NTD\/PCT\/2016.1; 2016. \n                    http:\/\/www.who.int\/onchocerciasis\/resources\/9789241510011\/en\/\n                    \n                  . Accessed 27 Sept 2018"},{"key":"496_CR35","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1093\/cid\/ciw144","volume":"2016","author":"KK Frempong","year":"2016","unstructured":"Frempong KK, Walker M, Cheke RA, Tetevi EJ, Gyan ET, Owusu EO, et al. Does increasing treatment frequency address suboptimal responses to Ivermectin for the control and elimination of river blindness? Clin Infect Dis. 2016;2016:1338\u201347.","journal-title":"Clin Infect Dis"},{"key":"496_CR36","volume-title":"1st international workshop on onchocerciasis associated epilepsy 12\u201314 October 2017, Antwerp, Belgium abstract 24: 2017","author":"MKOB Mbonye","year":"2017","unstructured":"Mbonye MKOB, Gumisiriza N, Lawko T, Makumbi I, Idro R, Onen H, Colebunders R. Prevalence and annual incidence of nodding syndrome and other forms of epilepsy in onchocerciasis endemic areas in northern Uganda. In: 1st international workshop on onchocerciasis associated epilepsy 12\u201314 October 2017, Antwerp, Belgium abstract 24: 2017; 2017. \n                    https:\/\/www.uantwerpen.be\/images\/uantwerpen\/container42952\/files\/20171023%20Programma%20boekje%20FINAL.pdf\n                    \n                  . Accessed 27 Sept 2018."},{"key":"496_CR37","volume-title":"Estimated number of individuals in the country requiring preventive chemotherapy for onchocerciasis","author":"World Health Organisation","year":"2017","unstructured":"World Health Organisation. Global health observatory data repository. In: Estimated number of individuals in the country requiring preventive chemotherapy for onchocerciasis; 2017. \n                    http:\/\/apps.who.int\/gho\/data\/node.main.NTDONCTREAT?lang=en\n                    \n                  . Accessed 27 Sept 2018."}],"container-title":["Infectious Diseases of Poverty"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40249-018-0496-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40249-018-0496-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40249-018-0496-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,13]],"date-time":"2019-11-13T19:23:36Z","timestamp":1573673016000},"score":1,"resource":{"primary":{"URL":"https:\/\/idpjournal.biomedcentral.com\/articles\/10.1186\/s40249-018-0496-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,14]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["496"],"URL":"https:\/\/doi.org\/10.1186\/s40249-018-0496-2","relation":{},"ISSN":["2049-9957"],"issn-type":[{"type":"electronic","value":"2049-9957"}],"subject":[],"published":{"date-parts":[[2018,11,14]]},"assertion":[{"value":"18 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Guidelines for conducting studies on human participants will be followed and the study will adhere to the principles of the Declaration of Helsinki, Good Clinical Practice guidelines and all other applicable local and international standard scientific regulations. Ethical approval has been obtained from the ethical committee at the Ministry of Health of the Republic of South Sudan and from the ethics committee of the University of Antwerp, Belgium. Meetings with village leaders and community health workers will be conducted prior to the start of the study. The study aims and procedures will be explained and discussed, including the potential benefits to the participants themselves and the community. All study participants will be taken through the informed consent process, and parents or legal guardians will provide written consent for minors. In addition, adolescents (age 12\u201318\u00a0years) will provide assent in the presence of their parents or guardians.Names of individuals will be recorded during the initial household survey to identify those that need to be evaluated by a medical doctor\/neurologist for case confirmation. All personal information will be encoded and treated confidentially. Study participants\u2019 name-linked information and ID codes will be used only to communicate clinical results to participants for the benefit of treatment. All data and participants\u2019 private information will be uploaded to a Google server, to which only specified study personnel will have access. Persons with epilepsy will be referred for anti-epileptic treatment and other appropriate care.Participants will be allowed to withdraw from the study activities at any time, without giving reasons.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Study results will be presented during meetings with community leaders, local healthcare workers and the local population. The results of the study will be disseminated through publications in open source scientific peer reviewed journals and through presentations in scientific conferences.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"112"}}